FDA Approved: RASAGILINE — Supplemental Application (Alvogen, Inc.)

View source ↗

Summary

The FDA approved Alvogen's supplemental application for Rasagiline (generic) under an ANDA, enabling a generic Rasagiline tablet for Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

SUPPL AP for RASAGILINE (RASAGILINE)